Skip to content

The clinical research for scalp acupuncture treatment on first episode schizophrenia based on neuroimage

The clinical research for scalp acupuncture treatment on first episode schizophrenia based on neuroimage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080032
Enrollment
Unknown
Registered
2024-01-18
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Experimental group:Scalp acupuncture, antipsychotic drug
Control group:rTMS, antipsychotic drug

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: ? Patients who have been diagnosed with schizophrenia according to the DSM-V criteria by two doctors with senior professional titles for the first time; ? At least one item on the PANSS scale is above mild (>3 points); ? Age 18-45 years old, right-handed; ? Education level of junior high school or above; ? Schizophrenia has not been treated for =5 years; ? No systematic antipsychotic treatment in the 14 days before enrollment.

Exclusion criteria

Exclusion criteria: ? with history of chronic neurological disease, abuse of psychoactive substances, mental retardation, and other organic diseases; ? suicidal ideation; ? cannot cooperate with scalp acupuncture or rTMS treatment; ? MECT treatment in the past 6 months.

Design outcomes

Primary

MeasureTime frame
symptoms assessment;cognitive function;

Secondary

MeasureTime frame
Functional connectivity;safety indicator;

Countries

China

Contacts

Public ContactYanzhe Ning

Beijing Anding Hospital Affiliated to Capital Medical University

yanzhening0923@163.com+86 10 5830 3065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026